IMA
ImageneBio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.72
−5.98%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-36.9%
Return on equity
-34.5%
Return on assets
-40.9%
Return on invested capital
0.00x
Asset turnover
-$57.7M
Cash from operations
$12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026